Skip to main content


Investigational New Drugs

Investigational New Drugs 1/2003

Ausgabe 1/2003

Inhaltsverzeichnis ( 13 Artikel )

01.02.2003 | Ausgabe 1/2003

Different Effects of Vinblastine on the Polymerization of Isotypically Purified Tubulins from Bovine Brain

Israr A. Khan, Richard F. Ludueña

01.02.2003 | Ausgabe 1/2003

Effect of the Antitumor Drug Vinblastine on Nuclear βII-tubulin in Cultured Rat Kidney Mesangial Cells

Consuelo Walss-Bass, Jeffrey I. Kreisberg, Richard F. Ludueña

01.02.2003 | Ausgabe 1/2003

Reversal of Tumor-induced Immunosuppression by TGF-β Inhibitors

Slawomir Wojtowicz-Praga

01.02.2003 | Ausgabe 1/2003

Discovery and Preclinical Antitumor Efficacy Evaluations of LY32262 and LY33169

Thomas H. Corbett, Kathryn White, Lisa Polin, Juiwanna Kushner, Jennifer Paluch, Chuan Shih, Cora Sue Grossman

01.02.2003 | Ausgabe 1/2003

An Overview on the Antileukemic Potential of D-homo-aza- and Respective 17β-Acetamido-Steroidal Alkylating Esters

Charalambos Camoutsis, Dimitrios T.P. Trafalis

01.02.2003 | Ausgabe 1/2003

Primary Tumor, Lung and Kidney Retention and Antimetastasis Effect of NAMI-A Following Different Routes of Administration

Moreno Cocchietto, Sonia Zorzet, Alenka Sorc, Gianni Sava

01.02.2003 | Ausgabe 1/2003

A Phase I Clinical Trial of Spicamycin Derivative KRN5500 (NSC 650426) Using a Phase I Accelerated Titration “2B” Design

S.M. Gadgeel, R.R. Boinpally, L.K. Heilbrun, A. Wozniak, V. Jain, B. Redman, M. Zalupski, R. Wiegand, R. Parchment, P.M. LoRusso

01.02.2003 | Ausgabe 1/2003

A Phase I and Pharmacologic Study of Pyrazoloacridine and Cisplatin in Patients with Advanced Cancer

E. Claire Dees, Eric K. Rowinsky, Dennis A. Noe, Seamus O'Reilly, Alex A. Adjei, Kathy Elza-Brown, Ross C. Donehower

01.02.2003 | Ausgabe 1/2003

Phase I and Pharmacologic Study of the Human DNA Methyltransferase Antisense Oligodeoxynucleotide MG98 given as a 21-day Continuous Infusion Every 4 Weeks

Alison J. Davis, Karen A. Gelmon, Lillian L. Siu, Malcolm J. Moore, Carolyn D. Britten, Nisha Mistry, Henry Klamut, Susan D'Aloisio, Martha MacLean, Nancy Wainman, Debbie Ayers, Patricia Firby, Jeffrey M. Besterman, Gregory K. Reid, Elizabeth A. Eisenhauer

01.02.2003 | Ausgabe 1/2003

Phase II Trial of Antiepidermal Growth Factor Receptor Antibody C225 in Patients with Advanced Renal Cell Carcinoma

Robert J. Motzer, Robert Amato, Mary Todd, Wen-J Poo Hwu, Roger Cohen, Jose Baselga, Hyman Muss, Michael Cooper, Richard Yu, Michelle S. Ginsberg, Michael Needle

01.02.2003 | Ausgabe 1/2003

A Phase II Study of Rebeccamycin Analog NSC 655649 in Patients with Metastatic Colorectal Cancer

Sanjay Goel, Scott Wadler, Anthony Hoffman, Fabio Volterra, Cheryl Baker, Elliot Nazario, Percy Ivy, Alyson Silverman, Sridhar Mani

01.02.2003 | Ausgabe 1/2003

Phase II Study of Single Agent Paclitaxel in Adult Patients with Relapsed Acute Lymphocytic Leukemia

Dawn E. Colburn, Deborah A. Thomas, Francis J. Giles

01.02.2003 | Ausgabe 1/2003

Current Approaches to Novel Therapeutics in Pancreatic Cancer

Corina E. Akerele, Irina Rybalova, Howard L. Kaufman, Sridhar Mani

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.